Document is current
Any future updates will be listed below
-
Authors
Wang, Mingqiang
Yang, Dan
Ma, Yiming
Shi, Yunke
Lun, Jinping
Zhang, Chaoyue
Li, Xinbin
Shi, Yuchen
Cai, Hongyan
-
Funding
Funding for this research was provided by:
the Yunnan Provincial Education Department Scientific Research Fund Project (2024Y224)
the Yunnan Provincial Education Department Scientific Research Fund Project (2025J0162)
the Graduate Innovation Fund of Kunming Medical University (2025B009)
the Foundation Projects of Applied Basic Research Joint Science and Technology Ministry of Yunnan Province with Kunming Medical University (202401AY070001-356)
the Science and Technology Program of Yunnan Province (202401AT070068)
the National Natural Science Foundation of China (82260087)
the Program Innovative Research Team in Science and Technology (“Xingdian Talents” Support Project) of Yunnan Province (202405AS350014)
the Yunnan Health Training Project of High Level Talents (L-2019025)
the Famous Doctor Special Project of the Yunnan Health Training Project of High-Level Talents (RLMY20190006)
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 19 January 2026
First Online: 1 February 2026
Declarations
:
: This study did not involve informed consent from clinical patients. Ethical approval for this study (kmmu2021109, Mechanism of extracorporeal cardiac shock wave preventing and treating coronary heart disease by promoting endothelial progenitor Cells function via the PI3K/Akt/eNOS pathway). It was obtained from the Animal Ethics Committee of Kunming Medical University on February 26, 2021.
: All authors agree to the publication of this work.
: The authors declare no competing interests.
